Cancer Treatment Holdings, Inc.
CTHZ
OTC PK
| 02/28/2003 | 11/30/2002 | 08/31/2002 | 05/31/2002 | 02/28/2002 | |
|---|---|---|---|---|---|
| Revenue | -42.13% | 27.33% | 18.22% | 3.70% | 335.87% |
| Total Other Revenue | -145.90% | -800.00% | 60.49% | 100.00% | 95.29% |
| Total Revenue | -54.38% | -3.79% | 17.65% | 28.89% | 450.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -54.38% | -3.79% | 17.65% | 28.89% | 450.00% |
| SG&A Expenses | 60.82% | 74.61% | 76.99% | 45.31% | 12.07% |
| Depreciation & Amortization | 0.00% | 5.03% | 15.34% | 43.51% | 60.68% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 58.13% | 71.51% | 73.96% | 45.24% | 13.56% |
| Operating Income | -77.26% | -82.97% | -81.45% | -47.24% | 7.27% |
| Income Before Tax | -218.90% | -83.47% | -111.08% | -70.26% | -16.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -218.90% | -83.47% | -111.08% | -70.26% | -16.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -218.90% | -83.47% | -111.08% | -70.26% | -16.67% |
| EBIT | -77.26% | -82.97% | -81.45% | -47.24% | 7.27% |
| EBITDA | -81.37% | -87.07% | -85.21% | -47.38% | 9.30% |
| EPS Basic | -218.96% | -83.43% | -110.87% | -70.17% | -16.65% |
| Normalized Basic EPS | -87.30% | -83.28% | -73.19% | -42.71% | 1.13% |
| EPS Diluted | -218.96% | -83.43% | -110.87% | -70.17% | -16.65% |
| Normalized Diluted EPS | -87.30% | -83.28% | -73.19% | -42.71% | 1.13% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
